IconOVir Bio snags $77m Series A

IconOVir Bio Inc., a preclinical-stage biotechnology company, has raised $77 million in Series A financing.

IconOVir Bio Inc., a preclinical-stage biotechnology company, has raised $77 million in Series A financing. Nextech and Vida Ventures led the round.

Source: Press Release